SCHEMBL23912958

SCHEMBL23912958

COc1cc(-c2cn(C)nc2-c2ccc(OCc3ccc(Cl)cc3)cc2O)cc(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.41
NPSR1 Q6W5P4 6/20 0.40
MAPT P10636 4/20 0.40
MEN1 O00255 7/20 0.40
KMT2A Q03164 7/20 0.40
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
ALDH1A1 P00352 1/20 0.38
TMPRSS4 Q9NRS4 1/20 0.38
BRAF P15056 2/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19319790 0.93 ALOX5AP (0.44) ALOX5APNPSR1MAPTMEN1KMT2A
SCHEMBL19319775 0.85 NPSR1 (0.53) NPSR1MAPTMEN1KMT2AMAOA
SCHEMBL19319799 0.85 NPSR1 (0.47) NPSR1MAPTMEN1KMT2AMAOA
SCHEMBL19319800 0.81 MAOB (0.46) ALOX5APNPSR1MAPTMEN1KMT2A
SCHEMBL19319765 0.81 NPSR1 (0.52) NPSR1MAPTMEN1KMT2AMAOA
SCHEMBL19319749 0.81 CSNK1D (0.47) NPSR1MAPTMEN1KMT2AMAOA
SCHEMBL19319746 0.80 MAOB (0.48) NPSR1MAPTMEN1KMT2ARXRA
SCHEMBL19319743 0.80 MAPK1 (0.50) ALOX5APNPSR1MAPTMEN1KMT2A
SCHEMBL19319809 0.79 NPSR1 (0.46) NPSR1MAPTMEN1KMT2AMAOA
SCHEMBL19319805 0.78 MAPT (0.53) NPSR1MAPTMEN1KMT2AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11142504-B2 Substituted heterocycles as c-MYC targeting agents NORTHWESTERN UNIVERSITY (US) 2021-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11142504-B2 Substituted heterocycles as c-MYC targeting agents MYC, MYCBP, MYCBP2 ALOX5AP 4567/4885NPSR1 4023/4885MAPT 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.